Heidi A. Lane

Person

Biel-Benken, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical combinations for use in the treatment of neoplastic...
- Patent number 11,419,856
- Issue date Aug 23, 2022
- Basilea Pharmaceutica International AG
- Felix Bachmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of phospho-Akt as a biomarker of drug response
- Patent number 10,724,072
- Issue date Jul 28, 2020
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of glu-tubulin as a biomarker of drug response to furazanobenzi...
- Patent number 10,656,162
- Issue date May 19, 2020
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Grant
Substituted mono- and polyazanaphthalene derivatives and their use
- Patent number 10,487,075
- Issue date Nov 26, 2019
- Basilea Pharmaceutica International AG
- Jens Pohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 10,222,377
- Issue date Mar 5, 2019
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of acetylated tubulin as a biomarker of drug response to furaza...
- Patent number 10,067,120
- Issue date Sep 4, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Grant
Use of phospho-Akt as a biomarker of drug response
- Patent number 10,006,078
- Issue date Jun 26, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of glu-tubulin as a biomarker of drug response to furazanobenzi...
- Patent number 9,995,754
- Issue date Jun 12, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 9,970,938
- Issue date May 15, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of acetylated tubulin as a biomarker of drug response to furaza...
- Patent number 9,476,889
- Issue date Oct 25, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of stathmin as a biomarker of drug response to furazanobenzimid...
- Patent number 9,366,682
- Issue date Jun 14, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of solid tumors with rapamycin derivatives
- Patent number 8,877,771
- Issue date Nov 4, 2014
- Novartis Pharmaceuticals Corporation
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of solid tumors with rapamycin derivatives
- Patent number 8,778,962
- Issue date Jul 15, 2014
- Novartis Pharmaceuticals Corporation
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of solid tumors with rapamycin derivatives
- Patent number 8,436,010
- Issue date May 7, 2013
- Novartis Pharmaceuticals Corporation
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatment
- Patent number 8,410,131
- Issue date Apr 2, 2013
- Novartis Pharmaceuticals Corporation
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
p53 wild-type as biomarker for the treatment with mTOR inhibitors i...
- Patent number 7,749,698
- Issue date Jul 6, 2010
- Novartis AG
- Iwan Beuvink
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING NEOPLASTIC DISEASES
- Publication number 20250057844
- Publication date Feb 20, 2025
- SILLAJEN, INC.
- Heidi LANE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...
- Publication number 20250049801
- Publication date Feb 13, 2025
- SILLAJEN, INC.
- Heidi LANE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,2,4-OXADIAZOL-5-ONE DERIVATIVES FOR THE TREATMENT OF CANCER
- Publication number 20220402900
- Publication date Dec 22, 2022
- Basilea Pharmaceutica International AG
- Florian RICHALET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND...
- Publication number 20220370418
- Publication date Nov 24, 2022
- Basilea Pharmaceutica International AG
- Vassilis GENOUD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...
- Publication number 20220031670
- Publication date Feb 3, 2022
- Basilea Pharmaceutica International AG
- Felix BACHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...
- Publication number 20200390749
- Publication date Dec 17, 2020
- Basilea Pharmaceutica International AG
- Felix BACHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE
- Publication number 20200031811
- Publication date Jan 30, 2020
- Basilea Pharmaceutica International AG
- Jens Pohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS
- Publication number 20190142810
- Publication date May 16, 2019
- Basilea Pharmaceutica International AG
- Heidi LANE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20190010536
- Publication date Jan 10, 2019
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...
- Publication number 20180364254
- Publication date Dec 20, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20180306790
- Publication date Oct 25, 2018
- Basilea Pharmaceutica International AG
- Diane BRAGUER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE
- Publication number 20180002321
- Publication date Jan 4, 2018
- Basilea Pharmaceutica International AG
- Jens Pohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...
- Publication number 20170122934
- Publication date May 4, 2017
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20160320397
- Publication date Nov 3, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20160303092
- Publication date Oct 20, 2016
- Novartis Pharmaceuticals Corporation
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20140105895
- Publication date Apr 17, 2014
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20140080872
- Publication date Mar 20, 2014
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20140045897
- Publication date Feb 13, 2014
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...
- Publication number 20140024686
- Publication date Jan 23, 2014
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...
- Publication number 20140005237
- Publication date Jan 2, 2014
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF STATHMIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMID...
- Publication number 20130345263
- Publication date Dec 26, 2013
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20130296359
- Publication date Nov 7, 2013
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20130287769
- Publication date Oct 31, 2013
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20130253000
- Publication date Sep 26, 2013
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20130244951
- Publication date Sep 19, 2013
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20130059877
- Publication date Mar 7, 2013
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20120283285
- Publication date Nov 8, 2012
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
- Publication number 20120214774
- Publication date Aug 23, 2012
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
- Publication number 20120129881
- Publication date May 24, 2012
- Gregory Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A MTOR INHIBITOR AND A RAF K...
- Publication number 20110301184
- Publication date Dec 8, 2011
- Novartis AG
- Heidi Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Heidi A. Lane

Person

Patents Grantslast 30 patents

Pharmaceutical combinations for use in the treatment of neoplastic...

Use of phospho-Akt as a biomarker of drug response

Use of glu-tubulin as a biomarker of drug response to furazanobenzi...

Substituted mono- and polyazanaphthalene derivatives and their use

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of acetylated tubulin as a biomarker of drug response to furaza...

Use of phospho-Akt as a biomarker of drug response

Use of glu-tubulin as a biomarker of drug response to furazanobenzi...

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of acetylated tubulin as a biomarker of drug response to furaza...

Use of stathmin as a biomarker of drug response to furazanobenzimid...

Treatment of solid tumors with rapamycin derivatives

Treatment of solid tumors with rapamycin derivatives

Treatment of solid tumors with rapamycin derivatives

Cancer treatment

p53 wild-type as biomarker for the treatment with mTOR inhibitors i...

Patents Applicationslast 30 patents

METHODS OF TREATING NEOPLASTIC DISEASES

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...

1,2,4-OXADIAZOL-5-ONE DERIVATIVES FOR THE TREATMENT OF CANCER

PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND...

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...

SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE

MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...

USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE

SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE

USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...

USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...

USE OF STATHMIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMID...

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES

COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER

PHARMACEUTICAL COMBINATIONS COMPRISING A MTOR INHIBITOR AND A RAF K...